JP Morgan Maintains Overweight on Eli Lilly, Raises Price Target to $600
Portfolio Pulse from richadhand@benzinga.com
JP Morgan analyst Chris Schott maintains an Overweight rating on Eli Lilly (NYSE:LLY) and raises the price target from $510 to $600.
August 09, 2023 | 4:29 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
JP Morgan maintains an Overweight rating on Eli Lilly and raises the price target from $510 to $600, indicating a positive outlook for the company.
The raised price target by JP Morgan indicates a positive outlook for Eli Lilly. This could lead to increased investor confidence and potentially a rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100